HEPATITIS B REACTIVATION RISK IN PATIENTS WITH RHEUMATOLOGIC DISEASES UNDER BIOLOGIC TREATMENT

Gokcen P., ALTINKAYA E.

ACTA MEDICA MEDITERRANEA, cilt.37, sa.3, ss.1529-1533, 2021 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 37 Sayı: 3
  • Basım Tarihi: 2021
  • Doi Numarası: 10.19193/0393-6384_2021_3_244
  • Dergi Adı: ACTA MEDICA MEDITERRANEA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE
  • Sayfa Sayıları: ss.1529-1533
  • Sivas Cumhuriyet Üniversitesi Adresli: Evet

Özet

Introduction: Hepatitis B virus reactivation (HBVr) is a clinical entity that can occur due to the use of immunosuppressive medications and causes serious complications that can threaten survival. In this study, we aimed to investigate the effects of the biological agents used in rheumatology on HBVr in a large patient population.